Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Nuwellis, Inc. develops and commercializes medical devices for fluid management, primarily ultrafiltration systems like Aquadex, used to treat fluid overload in heart failure, critical care, and pediatric patients. Its products enable safe, precise fluid removal, improving clinical outcomes and reducing hospital readmissions. Serving hospitals and healthcare providers worldwide, the company focuses on innovation, clinical evidence, and regulatory compliance to enhance patient care and healthcare economics.
This description was generated via AI from an annual report. Updated about 1 year ago.